Tesla CEO Elon Musk took to his social media platform X to unveil his most recent weight loss while using a blood sugar ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Seemingly overnight, millions of people were taking the medicines, known as GLP-1s, while blockbuster drugs like Ozempic, Wegovy, Mounjaro, and Zepbound brought in billions for pharma companies, and a ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

The world's richest man, Elon Musk, showed off his weight loss while dressed up as 'Ozempic Santa' on X (formerly known as ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...